Valuation: Southern Acids (M)

Market Cap 42Cr 10Cr 9.22Cr 8.52Cr 7.72Cr 14Cr 979.98Cr 15Cr 102.48Cr 41Cr 513.45Cr 39Cr 38Cr 1.62TCr P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -47.09L -11.53L -10.29L -10L -9L -16.12L -11Cr -16.39L -1.14Cr -45.3L -5.73Cr -43.26L -42.34L -18Cr EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
19/10 Southern Acids (M) Berhad Reports Group Production Results for the Month of September 2026 CI
01/10 Southern Acids (M) Berhad Reassigns Lee Weng Hoong as Principal Officer, Effective October 1, 2026 CI
08/09 Southern Acids (M) Berhad Reports Group Production Results for the Month of August 2026 CI
28/08 Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
28/08 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
28/08 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Non Independent and Non Executive Director, Effective August 28, 2026 CI
28/08 Southern Acids (M) Berhad Announces Appointment of Dato' Sri Dr Low Kok Thye as Acting Chairman, Effective August 28, 2026 CI
26/08 Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
13/08 Southern Acids (M) Berhad Reports Group Production Results for the Month of July 2026 CI
05/08 Southern Acids (M) Berhad Announces Redesignation of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie from Independent Director to Non-Independent Director, Effective August 5, 2026 CI
27/07 Southern Acids (M) Berhad Announces Single Tier Final Dividend on Ordinary Share for Financial Year Ending March 31, 2027, Payable on 11 November 2026 CI
14/07 Southern Acids (M) Berhad Reports Group Production Results for the Month of June 2026 CI
16/06 Southern Acids (M) Berhad Reports Group Production Results for the Month of May 2026 CI
1 week+0.65%
Current month-0.65%
1 month+0.98%
3 months-0.65%
6 months-2.22%
Current year-3.14%
1 week 3.08
Extreme 3.08
3.11
1 month 3.01
Extreme 3.01
3.18
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.5
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 46 15/07/2015
Chief Tech/Sci/R&D Officer 38 16/07/2014
Corporate Secretary - 27/03/2023
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 46 28/08/2026
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.65%-5.23%-5.52% 10Cr
+4.88%+3.34%+17.50%+52.94% 4.98TCr
-0.74%+1.24%-14.58%+31.51% 3.51TCr
-0.88%+3.87%-12.58%-9.07% 1.58TCr
+0.07%-2.90%-27.48%-1.48% 1.03TCr
-0.50%-6.54%-9.09%+9.29% 483.26Cr
0.00%+1.49%-29.79%-30.23% 456.79Cr
-0.34%+1.40%-3.02%+12.45% 399.11Cr
+3.66%-11.09%-21.90%+308.06% 410.57Cr
+0.87%+4.83%-5.96%+12.21% 369.92Cr
Average +0.70%+0.33%-11.21%+38.02% 1.32TCr
Weighted average by Cap. +1.65%+1.64%-3.23%+36.66%

Financials

2025 2026
Net sales 110.6Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.57TCr 38Cr 268.75Cr 106.4Cr 1.35TCr 101.6Cr 99Cr 4.24TCr 93Cr 23Cr 20Cr 19Cr 17Cr 32Cr 2.17TCr 32Cr 226.84Cr 90Cr 1.14TCr 86Cr 84Cr 3.58TCr
Net income 3.67Cr 89.83L 80.22L 74.11L 67.16L 1.26Cr 85Cr 1.28Cr 8.92Cr 3.53Cr 45Cr 3.37Cr 3.3Cr 140.87Cr 3.74Cr 91.49L 81.7L 75.48L 68.4L 1.28Cr 87Cr 1.3Cr 9.08Cr 3.6Cr 46Cr 3.43Cr 3.36Cr 143.46Cr
Net Debt -37Cr -8.98Cr -8.02Cr -7.41Cr -6.71Cr -13Cr -852.46Cr -13Cr -89Cr -35Cr -446.64Cr -34Cr -33Cr -1.41TCr -43Cr -10Cr -9.32Cr -8.61Cr -7.8Cr -15Cr -990.92Cr -15Cr -103.63Cr -41Cr -519.18Cr -39Cr -38Cr -1.64TCr
Projected Income Statement - Annual - Southern Acids (M)
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
23/26/23 MYR 3.080 0.00% 5,000
21/26/21 MYR 3.080 -0.65% 5,000
20/26/20 MYR 3.100 +1.31% 42,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock